TREM2 Agonism for Alzheimer's Disease

Mechanistic description

TREM2 is a microglial surface receptor regulating phagocytosis and survival. Loss-of-function TREM2 variants (R47H) increase AD risk ~3-fold. Therapeutic TREM2 activation may enhance amyloid plaque clearance and modulate neuroinflammation, though stage-dependent effects complicate therapeutic application.

Mechanism / pathway

TREM2
→
neurodegeneration

Evidence for (4)

TREM2 R47H variant associated with increased AD risk (~3-fold)

PMID:22683683
TREM2 deficiency impairs microglial clustering around plaques

PMID:26220941
TREM2 agonism promotes microglial phagocytosis of amyloid-β

PMID:29195064
AL002 (anti-TREM2 agonist) completed Phase I with acceptable safety

PMID:NCT03635047

Evidence against (4)

Complete TREM2 deficiency reduces plaque-associated neuritic dystrophy and improves memory in some models

PMID:28930663
TREM2 haploinsufficiency protects against tau-mediated neurodegeneration in PS19 mice

PMID:29686424
5xFAD mice lack significant tau pathology and neurodegeneration seen in human AD

PMID:review
Chronic microglial activation drives IL-1β, TNFα, complement cascades exacerbating tau pathology

PMID:review

Evidence matrix

4 supporting 4 contradicting

50% supporting

Supporting

TREM2 R47H variant associated with increased AD risk (~3-fold) PMID:22683683
TREM2 deficiency impairs microglial clustering around plaques PMID:26220941
TREM2 agonism promotes microglial phagocytosis of amyloid-β PMID:29195064
AL002 (anti-TREM2 agonist) completed Phase I with acceptable safety PMID:NCT03635047

Contradicting

Complete TREM2 deficiency reduces plaque-associated neuritic dystrophy and improves memory in some models PMID:28930663
TREM2 haploinsufficiency protects against tau-mediated neurodegeneration in PS19 mice PMID:29686424
5xFAD mice lack significant tau pathology and neurodegeneration seen in human AD PMID:review
Chronic microglial activation drives IL-1β, TNFα, complement cascades exacerbating tau pathology PMID:review

Cite this hypothesis

Citation

envelope-repair (2026). TREM2 Agonism for Alzheimer's Disease. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-3924cdba57

BibTeX

@misc{scidex_hypothesis_h3924cdb,
  title        = {TREM2 Agonism for Alzheimer's Disease},
  author       = {envelope-repair},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-3924cdba57},
  note         = {SciDEX artifact hypothesis:h-3924cdba57}
}